NCT04928300View on ClinicalTrials.gov

Low Dose Dexmedetomidine Versus Ketamine in Multiple Fracture Ribs

PHASE3RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 12, 2021

Primary Completion Date

July 1, 2027

Study Completion Date

July 25, 2027

Conditions
Rib Fractures
Interventions
DRUG

Dexmedetomidine

low dose dexmedetomidine infusion 0.2 µ/kg/hour IV for 5 days.

DRUG

Ketamine

low dose ketamine infusion 2.5 µ/kg/min for 5 days.

OTHER

0.9% saline

the same dose and duration of normal saline will be given for 5 days.

Trial Locations (1)

Assuit universi

RECRUITING

Assiut university hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04928300 - Low Dose Dexmedetomidine Versus Ketamine in Multiple Fracture Ribs | Biotech Hunter | Biotech Hunter